Evaluation of a New CZT System

NCT ID: NCT01084356

Last Updated: 2010-03-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to check if the new CZT system has an advantage in detection of small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel node, in comparison with the techniques in use.

Participants: 100 subjects male and female that come to the institute of nuclear medicine for routine screening examinations.

The CZT screening takes 10 minutes and does not require any extra intervention to the routine screening.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parathyroid Adenoma Thyroid Adenoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hand

patients admitted for Tc MDP for evaluation of carpal/metacarpal and finger bone lesions

No interventions assigned to this group

thyroid

patients admitted for Tc thyroid scan

No interventions assigned to this group

parathyroid

patients investigated for parathyroid adenoma

No interventions assigned to this group

sentinel node

patients who are due to sentinel node biopsy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age over 18

Exclusion Criteria

* pregnancy
* patients unable to understand and sign an informed consent
* age under 18
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tel-Aviv Sourasky Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tel Aviv SoUrasky medical center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Einat Even Sapir, PhD, MD

Role: PRINCIPAL_INVESTIGATOR

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Einat Even Sapir, PhD,MD

Role: CONTACT

972-3-6974444 ext. 3536

Ayelet Kurzband, BA

Role: CONTACT

972-3-6974444 ext. 3536

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Einat Even Sapir, PhD, MD

Role: primary

972-3-6974444 ext. 3536

Ayelet Kurzband, BA

Role: backup

972-3-6974444 ext. 3536

References

Explore related publications, articles, or registry entries linked to this study.

Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, Hutton B, Sharir T, Haim SB, Haim SB. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med. 2009 Apr;50(4):635-43. doi: 10.2967/jnumed.108.060020.

Reference Type BACKGROUND
PMID: 19339672 (View on PubMed)

Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 2008 Dec;191(6):1805-15. doi: 10.2214/AJR.07.3693.

Reference Type BACKGROUND
PMID: 19020253 (View on PubMed)

Mueller B, O'Connor MK, Blevis I, Rhodes DJ, Smith R, Collins DA, Phillips SW. Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med. 2003 Apr;44(4):602-9.

Reference Type BACKGROUND
PMID: 12679406 (View on PubMed)

Ketchum LE. New equipment in nuclear medicine, part 1: solid-state detectors. J Nucl Med. 1998 Nov;39(11):15N, 35N-36N. No abstract available.

Reference Type BACKGROUND
PMID: 9829562 (View on PubMed)

Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc. 2005 Jan;80(1):24-30. doi: 10.1016/S0025-6196(11)62953-4.

Reference Type BACKGROUND
PMID: 15667025 (View on PubMed)

O'Connor MK, Phillips SW, Hruska CB, Rhodes DJ, Collins DA. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J. 2007 Jan-Feb;13(1):3-11. doi: 10.1111/j.1524-4741.2006.00356.x.

Reference Type BACKGROUND
PMID: 17214787 (View on PubMed)

Tsuchimochi M, Hayama K, Oda T, Togashi M, Sakahara H. Evaluation of the efficacy of a small CdTe gamma-camera for sentinel lymph node biopsy. J Nucl Med. 2008 Jun;49(6):956-62. doi: 10.2967/jnumed.108.050740. Epub 2008 May 15.

Reference Type BACKGROUND
PMID: 18483107 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TASMC-10-EES-0649-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.